Show Navigation

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
{ 4767 images found }

Loading ()...

  • 23 FEBRUARY 2008 -- MAE SOT, TAK, THAILAND: Clinic workers try to start an IV in Ti Su Wa, a 2 year old Karen boy at the Mae Tao Clinic in Mae Sot, Thailand. His mother said he had been sick for more than a week but that she couldn't afford medical care in Burma so she crossed illegally to Thailand to get treatment at the clinic. The clinic treated more than 80,000 people in 2007, all Burmese. Most of them are living illegally in Thailand, but many come to the clinic from Burma because they either can't afford medical care in Burma or because it isn't available to them. There are millions of Burmese refugees living in Thailand. Many live in refugee camps along the Thai-Burma (Myanmar) border, but most live in Thailand as illegal immigrants. They don't have papers and can not live, work or travel in Thailand but they do so "under the radar" by either avoiding Thai officials or paying bribes to stay in the country. Most have fled political persecution in Burma but many are simply in search of a better life and greater economic opportunity.  Photo by Jack Kurtz
    BurmaMigrants001.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese woman walks to the SMRU clinic in Mae Kasa. Thailand. She had crossed the Moei River from Burma (in the background). Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics046.jpg
  • 23 FEBRUARY 2008 -- MAE SOT, TAK, THAILAND: Ban Di Tah, a Buddhist monk from Burma, gets treatment for malaria at the Mae Tao Clinic in Mae Sot, Thailand. Malaria is one the most common ailments treated at the clinic. The clinic treated more than 80,000 people in 2007, all Burmese. Most of them are living illegally in Thailand, but many come to the clinic from Burma because they either can't afford medical care in Burma or because it isn't available to them. There are millions of Burmese refugees living in Thailand. Many live in refugee camps along the Thai-Burma (Myanmar) border, but most live in Thailand as illegal immigrants. They don't have papers and can not live, work or travel in Thailand but they do so "under the radar" by either avoiding Thai officials or paying bribes to stay in the country. Most have fled political persecution in Burma but many are simply in search of a better life and greater economic opportunity.  Photo by Jack Kurtz
    BurmaMigrants004.jpg
  • 23 FEBRUARY 2008 -- MAE SOT, TAK, THAILAND: So Pai, a two year old Karen boy weighing about 13 pounds, waits for treatment for malnutrition at the Mae Tao Clinic in Mae Sot, Thailand. His family lives in Burma and had to travel more than six hours to bring the child to the clinic. The clinic treated more than 80,000 people in 2007, all Burmese. Most of them are living illegally in Thailand, but many come to the clinic from Burma because they either can't afford medical care in Burma or because it isn't available to them. There are millions of Burmese refugees living in Thailand. Many live in refugee camps along the Thai-Burma (Myanmar) border, but most live in Thailand as illegal immigrants. They don't have papers and can not live, work or travel in Thailand but they do so "under the radar" by either avoiding Thai officials or paying bribes to stay in the country. Most have fled political persecution in Burma but many are simply in search of a better life and greater economic opportunity.  Photo by Jack Kurtz
    BurmaMigrants003.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients coming to the Mawker Thai SMRU clinic in Mae Ku, Thailand take local transportation across the Moie River from Burma into Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics092.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand walk across the Moie River back to Burma. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics090.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand take local transportation across the Moie River back to Burma. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics089.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand take local transportation across the Moie River back to Burma. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics087.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand take local transportation across the Moie River back to Burma. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics086.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand take local transportation across the Moie River back to Burma. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics085.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese woman walks to the SMRU clinic in Mae Kasa. Thailand. She had crossed the Moei River from Burma (in the background). Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics045.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese woman walks to the SMRU clinic in Mae Kasa. Thailand. She had crossed the Moei River from Burma (in the background). Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics044.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  People cross the Moei River from Burma (on the left) to Thailand (on the right). Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics043.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand walk across the Moie River back to Burma, while a "bus" brings more patients across the river into Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics091.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese patients from the Mawker Thai SMRU clinic in Mae Ku, Thailand take local transportation across the Moie River back to Burma. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics088.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Burmese patients in the pharmacy waiting area at the SMRU clinic in Mae Kasa, Thailand. The clinic is less than 50 meters from the Thai-Burma border and sees only Burmese patients. Thais go to Thai government hospitals. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics036.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Burmese patients in the pharmacy waiting area at the SMRU clinic in Mae Kasa, Thailand. The clinic is less than 50 meters from the Thai-Burma border and sees only Burmese patients. Thais go to Thai government hospitals. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics035.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Burmese patients in the pharmacy waiting area at the SMRU clinic in Mae Kasa, Thailand. The clinic is less than 50 meters from the Thai-Burma border and sees only Burmese patients. Thais go to Thai government hospitals. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics034.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: Burmese patients in the outpatient waiting room at the SMRU clinic in Mae Kasa, Thailand. The clinic is less than 50 meters from the Thai-Burma border and sees only Burmese patients. Thais go to Thai government hospitals. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics029.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: Burmese patients in the outpatient waiting room at the SMRU clinic in Mae Kasa, Thailand. The clinic is less than 50 meters from the Thai-Burma border and sees only Burmese patients. Thais go to Thai government hospitals. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics028.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Burmese patients in the outpatient waiting room at the SMRU clinic in Mae Kasa, Thailand. Every patient who comes into the clinic is tested for malaria. The clinic is less than 50 meters from the Thai-Burma border and sees only Burmese patients. Thais go to Thai government hospitals. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics015.jpg
  • 18 FEBRUARY 2008 -- BONG TI, KANCHANABURI, THAILAND: LEAH, a Burmese refugee, reads her bible at the Bamboo School in Bong Ti, Thailand, about 40 miles from the provincial capital of Kanchanaburi. Sixty three children, most members of the Karen hilltribe, a persecuted ethnic minority in Burma, live at the school under the care of Catherine Riley-Bryan, whom the locals call MomoCat (Momo is the Karen hilltribe word for mother). She provides housing, food and medical care for the kids and helps them get enrolled in nearby Thai public schools. Her compound is about a half mile from the Thai-Burma border. She also helps nearby Karen refugee villages by digging water wells for them and providing medical care. Leah said she escaped to Thailand after the Burmese army murdered her father. She said she couldn't back to Burma because she is happy in Thailand and things are so bad in Burma now.  Photo by Jack Kurtz
    ThaiBurmaBorderBaanUnrak007.jpg
  • 23 FEBRUARY 2008 -- MAE SOT, TAK, THAILAND: A "long tailed boat" smuggles consumer goods from Thailand into Burma across the River Moei. These are numerous smuggling operations like this all along the border in Mae Sot. Boatmen bring consumer goods and construction supplies not available in Burma across the river avoiding the customs post. Thai and Burmese officials are allegedly involved in the smuggling schemes and get kickbacks and bribes from the boatmen. There are millions of Burmese refugees living in Thailand. Many live in refugee camps along the Thai-Burma (Myanmar) border, but most live in Thailand as illegal immigrants. They don't have papers and can not live, work or travel in Thailand but they do so "under the radar" by either avoiding Thai officials or paying bribes to stay in the country. Most have fled political persecution in Burma but many are simply in search of a better life and greater economic opportunity.  Photo by Jack Kurtz
    BurmaMigrants005.jpg
  • 23 FEBRUARY 2008 -- MAE SOT, TAK, THAILAND: Ti Su Wa, a 2 year old Karen boy and his mother in the pediatrics ward at the Mae Tao Clinic in Mae Sot, Thailand. There are no beds in the ward, the children (and their parents) sleep on bamboo sleeping mats they bring with them. The clinic treated more than 80,000 people in 2007, all Burmese. Most of them are living illegally in Thailand, but many come to the clinic from Burma because they either can't afford medical care in Burma or because it isn't available to them. There are millions of Burmese refugees living in Thailand. Many live in refugee camps along the Thai-Burma (Myanmar) border, but most live in Thailand as illegal immigrants. They don't have papers and can not live, work or travel in Thailand but they do so "under the radar" by either avoiding Thai officials or paying bribes to stay in the country. Most have fled political persecution in Burma but many are simply in search of a better life and greater economic opportunity.  Photo by Jack Kurtz
    BurmaMigrants002.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, leads a class on cardiac care for medics in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics117.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Medics at the SMRU Clinic in Maela Refugee Camp at a workshop on a cardiac care. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics115.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Medics at the SMRU Clinic in Maela Refugee Camp at a workshop on a cardiac care. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics114.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese Muslim woman about her child in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics112.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Burmese refugees wait to get into the SMRU clinic in Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics110.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Dr. CINDY CHU, an American, (RIGHT) consults with her Burmese colleague, Dr. SEZN SEZN THI, about a patient's x-ray  at the Mawker Thai SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia. PHOTO BY JACK KURTZ
    SMRUClinics100.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese women leave the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics094.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A teenager with an infected leg is admitted to the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics093.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A Burmese girl eats a crushed ice desert at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics074.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Women and their babies at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics072.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  People waiting to see a doctor watch television through a slatted wall at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics069.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A health care worker does a prenatal examine on a Burmese woman at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics065.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A new mother sits with her premature newborn, who is in an incubator, at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics061.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A medic takes a baby's pulse in the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics060.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: People leave the MSRU clinic in Mae Kasa at the end of the day. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics059.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese pharmacy worker talks to a patient about the medications she is receiving at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics057.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:A Burmese woman waits to see a doctor at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics055.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese technician counts white blood cells during a malaria test in the lab in the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics054.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese technician counts white blood cells during a malaria test in the lab in the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics052.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese technician counts white blood cells during a malaria test in the lab in the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics050.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A woman with an etopic pregnancy is transported to a Thai hospital for further treatment. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics042.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese pharmacy worker talks to a patient about the medications she is receiving at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics038.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: A Burmese man tries to medicate his son at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics032.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A woman who had gone into shock because of an etopic pregnancy in the SMRU clinic intensive care room at the Mae Kasa clinic. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics022.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: A woman with her children in the SMRU clinic in Mae Kasa. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics019.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A baby in an incubator at the SMRU clinic in Mae Kasa. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics017.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: A Burmese woman holds her newborn grandchild while the child's mother looks on in the delivery area of the SMRU clinic in Mae Kasa, Thailand.  Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics013.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: A Burmese woman holds her newborn grandchild in the delivery area of the SMRU clinic in Mae Kasa, Thailand.  Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics012.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese boy in front of his ward at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics011.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese boy in front of his ward at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics010.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A woman helps cool down her husband, who has malaria, in the intensive care room of the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics008.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Dr. FRANCOIS NOSTEN, Director of the Shoklo Malaria Research Unit, helps a Burmese patient who collapsed in the waiting area of the SMRU clinic in Mae Kasa, Thailand.  Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics004.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Burmese Dr. AUNG PYAE PHYO and Dr. FRANCOIS NOSTEN consult about malaria at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics001.jpg
  • 27 FEBRUARY 2008 -- MAE SOT, TAK, THAILAND: Thai soldiers on the Thai side of the border talk to Burmese cigarette smugglers on the Burmese side of the border along the Thai - Myanmar (Burma) border in Mae Sot, Thailand. Thai authority ends at the metal railing separating the men and Burmese smugglers line up along the rail to sell cigarettes and liquor to people on the Thai side of the rail. There are millions of Burmese migrant workers and refugees living in Thailand. Many live in refugee camps along the Thai-Burma (Myanmar) border, but most live in Thailand as illegal immigrants. They don't have papers and can not live, work or travel in Thailand but they do so "under the radar" by either avoiding Thai officials or paying bribes to stay in the country. Most have fled political persecution in Burma but many are simply in search of a better life and greater economic opportunity.  Photo by Jack Kurtz
    BurmaMigrants025.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, leads a class on cardiac care for medics in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics116.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, leads a class on cardiac care for medics in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics113.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   A Buddhist novice and his friend walk through the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics111.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese woman who is pregnant and has malaria in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics109.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese woman who is pregnant and has malaria in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics108.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese woman who is pregnant and has malaria in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics107.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese woman who is pregnant and has malaria in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics104.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese patient in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics103.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese patient in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics102.jpg
  • 22 MAY 2013 - MAELA, TAK, THAILAND:   Dr. MARGAREET TRIP, a Dutch pediatrician, talks to a Burmese patient in the SMRU Clinic in the Maela Refugee Camp. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the malaria parasite from a patient, progress that has made been in combating malaria will be lost and the disease could make a comeback in Southeast Asia.     PHOTO BY JACK KURTZ
    SMRUClinics101.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Dr. CINDY CHU, an American, (RIGHT) consults with her Burmese colleague, Dr. SEZN SEZN THI, about a patient's x-ray  at the Mawker Thai SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia. PHOTO BY JACK KURTZ
    SMRUClinics099.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A new mother sits with her premature newborn, who is in an incubator, at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics098.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A boy with a severe case of malaria lays in his bed while he awaits a lifesaving blood transfusion at the Mawker Thai SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics096.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A Burmese woman with her newborn at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics095.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Burmese lab technicians count patients' malaria loads at the Mawker Thai SMRU clinic in Mae Ku, Thailand. They count the number of parasites in the patient's blood. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics084.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Blood is drawn for malaria testing from an infant coming into the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics083.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Blood is drawn for malaria testing from a child coming into the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics082.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  The outpatient waiting area at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics081.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  Dr. CINDY CHU, an American physician, examines a child at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics080.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A Burmese health worker draws from a patient known to have malaria at the Mawker Thai SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics078.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  People participating in a test of malaria drugs relax in the observation room at the Mawker Thai SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics076.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A snack vendor at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics075.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A Burmese girl eats a crushed ice desert at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics073.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A snack vendor at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics071.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A family waits for their wife/mother at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics070.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  People waiting to see a doctor watch television through a slatted wall at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics068.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A health care worker does a prenatal examine on a Burmese woman at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics067.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A health care worker does a prenatal examine on a Burmese woman at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics066.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A health care worker does a prenatal examine on a Burmese woman at the SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics064.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND:  A child sleeps in a ward at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics063.jpg
  • 21 MAY 2013 - MAE KU, TAK, THAILAND: A health worker takes a blood for a malaria test on a patient at the SMRU clinic in Mae Ku. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.  PHOTO BY JACK KURTZ
    SMRUClinics062.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese medic takes a baby's temperature during the intake process at the SMRU clinic in Mae Kasa. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics058.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese health care worker draws blood for a malaria test from a patient checking in to the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics056.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese technician counts white blood cells during a malaria test in the lab in the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics053.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese technician counts white blood cells during a malaria test in the lab in the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics051.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese technician checks blood test results in the lab in the SMRU clinic in Mae Kasa, Thailand. Everybody who comes to the clinic is tested for malaria. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.   PHOTO BY JACK KURTZ
    SMRUClinics049.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese health care worker tends to a baby in an incubator at the SMRU clinic in Mae Kasa, Thailand. Babies are at high risk for being infected with malaria because their immune systems can't fight off the parasite. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics048.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese health care worker tends to a baby in an incubator at the SMRU clinic in Mae Kasa, Thailand. Babies are at high risk for being infected with malaria because their immune systems can't fight off the parasite. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics047.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Women in the obstetrics waiting area at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics041.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND: A woman waits to see a medic during a routine exam for her and her newborn child in the SMRU clinic in Mae Kasa. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics040.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  Vials of drugs to be prescribed to patients in the pharmacy area at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics039.jpg
  • 20 MAY 2013 - MAE KASA, TAK, THAILAND:  A Burmese man waits in the waiting room at the SMRU clinic in Mae Kasa, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though,  health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia.    PHOTO BY JACK KURTZ
    SMRUClinics037.jpg
Next
  • Facebook
  • Twitter
x

Jack Kurtz, Photojournalist & Travel Photographer

  • Published Work
  • Photographs
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Jack on Instagram
  • About
  • Contact
  • My Occasional Blog
  • Portfolios on Behance
  • Portfolio